title: [Complement activation by killed polyvalent bacterial vaccine on the pleurodesis].
abstract: Broncasma Berna (B.B.) prepared from killed polyvalent bacterial vaccine is used as a pleural irritant for pleurodesis on patients with spontaneous pneumothorax. The effects of B.B. on the complement system in vivo after injections into pleural spaces were investigated. Five patients with spontaneous pneumothorax underwent intrapleural injections of B.B. Increased body temperatures with positive C-reactive proteins and increased polymorphonuclear leukocyte counts in peripheral blood were observed in all patients. Serum levels of complement components (Clq, Cls, C4, C3 and B), hemolytic activity of complement (CH50) and plasma levels of C3a were gradually elevated after intrapleural injections of B.B. Analysis of pleural fluids from 4 patients showed that levels of C3a and C5a were increased compared with plasma levels, and an accumulation of polymorphonuclear leukocytes were observed. These findings suggest that intrapleural injections of B.B. activate the complement system and cause inflammatory reactions accompanied by an increase of C3a and C5a and an accumulation of polymorphonuclear leukocytes. Such inflammatory reactions might inversely induce the synthesis of complement components and promote the migration of polymorphonuclear leukocytes from bone marrow. The deposit of fibrin during these inflammatory processes might contribute to the development of pleurodesis. These inflammatory reactions might be mediated through the activation of the classical complement pathway by B.B.
authors.affiliation: Department of Medicine, Jichi Medical School.
authors.forename: T
authors.initials: T
authors.lastname: Yoshio
authors.forename: S
authors.initials: S
authors.lastname: Kano
authors.forename: Y
authors.initials: Y
authors.lastname: Yukiyama
authors.forename: E
authors.initials: E
authors.lastname: Noguchi
mesh_terms: D000328:Adult; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D003167:Complement Activation; D003171:Complement Pathway, Classical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011030:Pneumothorax / Q000276:immunology* / Q000628:therapy; D015164:Vaccines, Inactivated / Q000627:therapeutic use
chemical_list: D001428:Bacterial Vaccines; D015164:Vaccines, Inactivated